An important goal of our laboratory is to clarify the role of the immune system during cancer therapy. Standard systemic therapies have established antitumor properties; however, the immune modulating effect of traditional cytotoxic drugs and newer targeted agents has received less attention. Understanding the immune modulating properties of these agents paves the way for combination therapies that include novel cancer vaccines.
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Kim Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Wang Y, Sparwasser T, Figlin R, Kim HL.
Cancer Res. 2014;74(8):2217-2228.
Morello M, Minciacchi VR, de Candia P, Yang J, Posadas E, Kim HL, Griffiths D, Bhowmick N, Chung L, Gandellini P, et al.
Cell Cycle. 2013;12(22):3526-3536.
Li P, Grigorenko E, Funari V, Enright E, Zhang H, Kim HL.